Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie

AZN, Daiichis Enhertu Gets FDA Nod for Two New Breast Cancer Settings

AstraZeneca and Daiichi win FDA approval for Enhertu in two new HER2-positive early breast cancer treatment settings.…

AstraZeneca Gets FDA Nod for New Hypertension Drug Baxfendy

AZNs Baxfendy wins FDA nod as the first aldosterone synthase inhibitor for adults with uncontrolled hypertension.…

AstraZeneca wins US approval for first-in-class blood pressure drug and expands cancer treatment Enhertu

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured US approval for Baxfendy, the first in a new class of blood pressure medication…

AstraZeneca wins US approval for first-in-class blood pressure drug and expands cancer treatment Enhertu

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured US approval for Baxfendy, the first in a new class of blood pressure medication…

AstraZeneca wins US FDA approval for hypertension drug Baxfendy

…

Top Stock Reports for Costco, Coca-Cola & AstraZeneca

Costco, Coca-Cola and AstraZeneca lead Zacks top stock reports as strong earnings, growth drivers and pipeline momentum lift outlooks.…

Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?

AZN and ABBV both boast strong drug pipelines and growth outlooks, but differences in valuation, dividends and LOE risks set…

Mineralys: Hold As Hypertension OSA Data Barely Delivers And AstraZeneca On The Move

…

IRW-News: ACCESS Newswire: AstraZeneca und OMP demonstrieren auf dem Gartner Supply Chain Symposium/Xpo(TM) 2026 Planung im Tempo des Wandels

IRW-PRESS: ACCESS Newswire: AstraZeneca und OMP demonstrieren auf dem Gartner Supply Chain Symposium/Xpo(TM) 2026 Planung im Tempo des WandelsWie eine…

Total Voting Rights and Admission of Shares

1 May 2026Total Voting Rights and Notification of Admission of Further Securities to Trading (PRM 1.6.4R)Total Voting RightsThe following notification…

AstraZeneca stock falls after FDA panel votes against new cancer drug

The advisory panel wasnt convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.…

AstraZeneca falls as FDA advisers reject breast cancer drug use

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 1.9% to 13,688p after the US regulators advisory panel declined to back its camizestrant…

FDA ODAC vote on camizestrant in breast cancer

01 May 2026Update on FDA Advisory Committee vote on camizestrant in combination with a CDK4/6 inhibitor for advanced HR-positive breast…

JEFFERIES stuft ASTRAZENECA auf Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Astrazeneca auf "Buy" mit einem Kursziel von 18000…

JPMORGAN stuft ASTRAZENECA auf Overweight

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca auf "Overweight" mit einem Kursziel von 16000…

Citi raises AstraZeneca earnings forecast and maintains buy rating ahead of second-half pipeline catalysts

Bank lifts 2026 core earnings per share estimate 2% to $10.30 after first-quarter beat, sees positive risk-reward into late-year readouts…

+++ Geschäftszahlen +++: Versicherer Talanx übertrifft Gewinnerwartungen

Iran-Krieg treibt Gewinn von TotalEnergies an +++ Starke Medikamentennachfrage stützt AstraZeneca und GSK an +++ Wacker Chemie verbessert operatives Ergebnis…

FTSE 100 Live: Sluggish start expected as Lloyds, AstraZeneca and Jet2 report

7.15am: FTSE 100 heading for sluggish start The FTSE 100 may be heading for a sluggish start on Wednesday, as…

FTSE 100 Live: Sluggish start as AstraZeneca, Haleon results disappoint

8.15am: FTSE opens in red The FTSE 100 has opened 40 points lower at 10,292. St Jamess Place, GSK and Haleon…

AstraZeneca sticks to its guns after strong first-quarter revenue growth

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharmaceuticals giant, has reconfirmed its full-year 2026 guidance after reporting first-quarter total...…

Citi sees Daiichi supply review as immaterial for AstraZeneca

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharmaceuticals giant, faces no material risk from its Japanese partner Daiichi Sankyos decision…

Saphnelo self-administration approved in the US

27 April 2026Saphnelo approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosusFirst-in-class Saphnelo Pen now…

Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights

Astrazeneca (AZN) concluded the recent trading session at $192.3, signifying a -1.29% move from its prior days close.…

AstraZenecas Ultomiris Meets Goal in Rare Kidney Disease Study

AZNs Ultomiris hits key goal in IgAN study, showing early proteinuria reduction as it eyes accelerated approval in major markets.…

AstraZenecas tozorakimab treble puts $5bn sales ceiling in sight, says Citi

A third consecutive phase III success for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) tozorakimab in chronic obstructive pulmonary disease (COPD) has reinforced...…

AstraZenecas Ultomiris hits primary endpoint in rare kidney disease trial

AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) Ultomiris has met its primary endpoint in a phase III trial targeting immunoglobulin A nephropathy (IgAN),…

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know

Astrazeneca (AZN) reached $201.21 at the closing of the latest trading day, reflecting a -1.55% change compared to its last…

AstraZeneca faces China headwinds and key drug launches as two banks back 20% upside

UBS and Citi both maintain buy ratings on the Anglo-Swedish drugmaker ahead of its first-quarter results, with a rich pipeline…

Result of AGM

9 April 2026Results of Annual General Meeting held on 9 April 2026AstraZeneca PLC announced the results of the voting at…

AZN vs. MRK: Which Oncology Stock Offers Better Investment Potential?

Though both dominate oncology, a stronger growth outlook and clearer targets may give AstraZeneca an edge over Merck.…

The Zacks Analyst Blog Highlights AstraZeneca, HSBC, Walt Disney, Oak Valley Bancorp and BV Financial

AstraZeneca (AZN) leads Zacks Research highlights with strong drug growth and pipeline momentum, while HSBC and Disney navigate costs and…

AstraZeneca Aktie: "Top Pick" mit neuem Rückenwind!

New York (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von Morgan Stanley:Morgan Stanley habe das Kursziel für die Aktie von AstraZeneca plc (ISIN: GB0009895292,…

Top Research Reports for AstraZeneca, HSBC & Walt Disney

AstraZenecas strong drug portfolio and pipeline fuel growth targets, while HSBC restructures and Disney balances streaming gains against rising costs.…

AstraZenecas liver cancer breakthrough puts Imfinzi on course to become a super-blockbuster drug

A positive phase three trial result in a hard-to-treat cancer adds fresh momentum to one of AstraZenecas most important growth…

AstraZeneca: The Bigger Picture Remains Solid Growth Amidst Improving Margins And Returns

…

Astrazeneca (AZN) Rises Higher Than Market: Key Facts

Astrazeneca (AZN) concluded the recent trading session at $203.49, signifying a +1.37% move from its prior days close.…

US bank sees AstraZeneca HPP drug data as supportive of $2.6bn forecast with upside to $4.4bn despite mixed trial results

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has reported mixed phase three trial data for efzimfotase alfa, its treatment for hypophosphatasia, a rare…

dpa-AFX ProFeed